Home » Topics » Regulatory » Patents

Patents
RSS

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Fibrinogen antagonist research continues at Merck & Co.

Oct. 11, 1996

MTP inhibitors from Bristol-Myers Squibb

Oct. 11, 1996

Wakunaga discloses angiotensin II antagonists

Oct. 11, 1996

Endothelin antagonists from Banyu

Oct. 11, 1996

Warner-Lambert claims endothelin antagonists

Oct. 11, 1996

Dual thromboxane synthase/lipoxygenase inhibitors from Nikken Chemicals

Oct. 11, 1996

Calpain inhibitors reported by Warner-Lambert

Oct. 11, 1996

New muscarinic antagonists from Schering-Plough

Oct. 11, 1996

Potential antipsychotic agents disclosed by Pharmacia & Upjohn

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...